Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)

被引：1

作者：

Cao, Guo-zhen ^{[1
,2
,3
]}

Ma, Li-ying ^{[1
,2
,3
]}

Zhang, Zong-hui ^{[1
,4
]}

Wang, Xiao-lin ^{[2
]}

Hua, Jing-han ^{[1
,2
,3
]}

Zhang, Jia-hui ^{[1
,2
,3
]}

Lv, Yang ^{[1
,2
,3
]}

Zhang, Shao-bo ^{[1
,4
]}

Ou, Jian ^{[5
]}

Lin, Wen-chu ^{[1
,2
,3
]}

机构：

[1] Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Peoples R China

[2] Univ Sci & Technol China, Hefei 230036, Peoples R China

[3] Chinese Acad Sci, Key Lab High Magnet Field &Beam Phys Biol, Hefei Inst Phys Sci, Hefei 230031, Peoples R China

[4] Anhui Med Univ, Sch Basic Med, Hefei 230032, Peoples R China

[5] Nanjing Med Univ, Suzhou Municipal Hosp, Ctr Reprod & Genet, Affiliated Suzhou Hosp, Suzhou 215002, Peoples R China

来源：

ACTA PHARMACOLOGICA SINICA | 2023年 / 44卷 / 05期

关键词：

D O I：

10.1038/s41401-022-01019-w

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：1105 / 1106

页数：2

共 50 条

[21] AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
Zhao, Ren
Zhou, Shun
Xia, Bing
Zhang, Cui-ying
Hai, Ping
Zhe, Hong
Wang, Yan-yang
BMC CANCER, 2016, 16
[22] AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
Ren Zhao
Shun Zhou
Bing Xia
Cui-ying Zhang
Ping Hai
Hong Zhe
Yan-yang Wang
BMC Cancer, 16
[23] SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (vol 25, pg 2679, 2023)
Garcia-Campelo, Rosario
Sullivan, Ivana
Arriola, Edurne
Insa, Amelia
Vidal, Oscar Juan
Cruz-Castellanos, Patricia
Moran, Teresa
Reguart, Noemi
Zugazagoitia, Jon
Domine, Manuel
CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09): : 2760 - 2762
[24] Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram (vol 170, pg 74, 2022)
Jia, Xiaohui
Chu, Xiangling
Jiang, Lili
Li, Yanlin
Zhang, Yajuan
Mao, Ziyang
Liang, Ting
Du, Yonghao
Xu, Longwen
Shen, Yuan
Niu, Gang
Meng, Rui
Ni, Yunfeng
Su, Chunxia
Guo, Hui
LUNG CANCER, 2022, 171 : 121 - 125
[25] PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Chabanon, Roman M.
Muirhead, Gareth
Krastev, Dragomir B.
Adam, Julien
Morel, Daphne
Garrido, Marlene
Lamb, Andrew
Henon, Clemence
Dorvault, Nicolas
Rouanne, Mathieu
Marlow, Rebecca
Bajrami, Ilirjana
Cardenosa, Marta Llorca
Konde, Asha
Besse, Benjamin
Ashworth, Alan
Pettitt, Stephen J.
Haider, Syed
Marabelle, Aurelien
Tutt, Andrew N. J.
Soria, Jean-Charles
Lord, Christopher J.
Postel-Vinay, Sophie
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (03): : 1211 - 1228
[26] First-Line Immunotherapy for Non-Small-Cell Lung Cancer (vol 40, pg 586, 2022)
Reck, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) : 1265 - 1265
[27] evaluation of PD-L1 expression on circulating tumour cells in small cell lung cancer (vol 11, pg 440, 2022)
Acheampong, E.
Abed, A.
Morici, M.
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (05) : 950 - 952
[28] NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib
Gu, Guoqing
Hu, Chenxi
Hui, Kaiyuan
Chen, Ting
Zhang, Huiqin
Jiang, Xiaodong
AGING-US, 2021, 13 (10): : 13941 - 13953
[29] MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis
Tong, Qin
Ouyang, Shuming
Chen, Rui
Huang, Jie
Guo, Linlang
AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (09): : 1938 - +
[30] Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1 (vol 18, pg 1065, 2022)
Feng, Zhiping
Hom, Marisa E.
Bearrood, Thomas E.
Rosenthal, Zachary C.
Fernandez, Daniel
Ondrus, Alison E.
Gu, Yuchao
Mccormick, Aaron K.
Tomaske, Madeline G.
Marshall, Cody R.
Kline, Toni
Chen, Che-Hong
Mochly-Rosen, Daria
Kuo, Calvin J.
Chen, James K.
NATURE CHEMICAL BIOLOGY, 2025, 21 (02) : 309 - 309

← 1 2 3 4 5 →